Лечение ревмат артрита

Лечение ревмат артрита

Сокращения, используемые в протоколе:
АРР — Ассоциация ревматологов России
АЦЦП — антитела к циклическому цитруллинированному пептиду
БПВП — базисные противовоспалительные препараты
ВАШ — Визуальная Аналоговая шкала
ГИБП — генно-инженерные биологические препараты
ГИБТ – генно-инженерная биологическая терапия
ГК — глюкокортикостероиды
ЖКТ — желудочно-кишечный тракт
ЗППП — заболевания, передающиеся половым путем
ЛС — лекарственные средства
МТ – метотрексат
ЛЕФ – лефлуномид
СС – сульфасалазин
ООСЗ – общая оценка состояния здоровья
МРТ — магниторезонансная томография
НПВП — нестероидные противовоспалительные препараты
ОСЗ — общее состояние здоровья
РА — ревматоидный артрит
РФ — ревматоидный фактор
СРБ — С-реактивный белок
УЗИ — ультразвуковое исследование
ФК — функциональный класс
ЧПС- число припухших суставов
ЦОГ — циклооксигеназа
ФГДС – фиброгастродуоденоскопия
ФНО-α — фактор некроза опухолей-альфа
ЭКГ — электрокардиограмма
ЭХО КГ – эхокардиограмма
EULAR- Европейская антиревматическая лига (European League Against Rheumatism)
ACR- Американская Коллегия ревматологов (American College of Rheumatology)

Список разработчиков протокола:
1)    Турдалин Нурлан Бостыбаевич – кандидат медицинских наук, директор ГКП на ПХВ «Городской ревматологический центр» Управления Здравоохранения г.Алматы, главный внештатный ревматолог МЗСР РК.
2)      Габдулина Гулжан Хамзенична – кандидат медицинских наук, доцент кафедры общей врачебной практики №1 «Казахский национальный медицинский университет им С.Д. Асфендиярова».
3)      Аубакирова Бакыт Амантаевна —  главный внештатный ревматолог г.Астана, руководитель Городского ревматологического центра при Городской поликлинике №7 Управления здравоохранения г.Астаны.
4)      Аманжолова Айнаш Сейдахметовна — Казахский Национальный медицинский Университет им. С.Д. Асфендиярова, кафедра общей врачебной практики №1 с курсом герантологии и гериатрии, ассистент.   
5)      Смагулова Газиза Ажмагиевна — доцент, кандидат медицинских наук, руководитель кафедры пропедевтики внутренних болезней и клинической фармакологии Западно-Казахстанского государственного медицинского университета им.М.Оспанова г.Актобе, клинический фармаколог.
 
Список рецензентов:
1)      Исаева Бакытшолпан Габдулхакимовна- доктор медицинских наук, профессор, заведующая кафедрой общей врачебной практики №1 «Казахский националный медициский университет  имени С.Д. Асфендиярова»,  ревматолог.
 
Конфликта интересов: нет.
 
Условия пересмотра: пересмотр протокола через 3 года после его опубликования и с даты его вступления в действие или при наличии новых методов с уровнем доказательности.

Приложение
Список использованной литературы по определению шкалы  уровня доказательности  основных лекарственных средств:
 
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
27. Maria E Suarez-Almazor,  Elaine Belseck,  Beverley Shea,  Peter Tugwell,  George A Wells.
Sulfasalazine for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews . Assessed as up-to-date: 27 April 1998 DOI: 10.1002/14651858.CD000958.  Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000958/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full
21. Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2014 Jun 10;(6):CD000957. doi: 10.1002/14651858.CD000957.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000957.pub2/abstract;jsessionid=263E5B8747EFACDC3DE718A95D252CC3.f01t03  или http://www.ncbi.nlm.nih.gov/pubmed/24916606
22. Dhaon P, Das SK, Srivastava R, Agarwal G, Asthana A. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study. Int J Rheum Dis. 2016 Jul 26. doi: 10.1111/1756-185X.12910. [Epub ahead of print]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27455886
23. Bianchi G, Caporali R, Todoerti M, Mattana P. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration. Adv Ther. 2016 Mar;33(3):369-78. doi: 10.1007/s12325-016-0295-8. Epub 2016 Feb 4.Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833794/
24. Conway R, Low C, Coughlan RJ, O’Donnell MJ, Carey JJ. Leflunomide Use and Risk of Lung Disease in Rheumatoid Arthritis: A Systematic Literature Review and Meta-analysis of Randomized Controlled Trials. J Rheumatol. 2016 May;43(5):855-60. doi: 10.3899/jrheum.150674. Epub 2016 Mar 15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26980577
25. Manathip Osiri , Beverley Shea , Vivian Welch , Maria E Suarez-Almazor , Vibeke Strand , Peter Tugwell and George A Wells. Leflunomide for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: July 2002.
Assessed as up-to-date: 19 July 2009. DOI: 10.1002/14651858.CD002047.  Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002047/full
26. Maria E Suarez-Almazor,  Elaine Belseck,  Beverley Shea,  Peter Tugwell,  George A Wells.
Cyclophosphamide for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews. Assessed as up-to-date: 29 August 2000  DOI: 10.1002/14651858.CD001157.  Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001157/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
28. John R Kirwan , Johannes WJ Bijlsma , Maarten Boers and Beverley Shea. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: January 2007. DOI: 10.1002/14651858.CD006356. Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006356/full
29. Lindsey Criswell , Kenneth Saag , K M Sems , Vivian Welch , Beverley Shea , George A Wells and Maria E Suarez-Almazor. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database of Systematic Reviews.Online Publication Date: July 1998. DOI: 10.1002/14651858.CD001158. Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001158/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
28. John R Kirwan , Johannes WJ Bijlsma , Maarten Boers and Beverley Shea. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: January 2007. DOI: 10.1002/14651858.CD006356. Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006356/full
29. Lindsey Criswell , Kenneth Saag , K M Sems , Vivian Welch , Beverley Shea , George A Wells and Maria E Suarez-Almazor. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database of Systematic Reviews.Online Publication Date: July 1998. DOI: 10.1002/14651858.CD001158. Available from:  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001158/full
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
 30. Atzeni F , Monguzzi A , Grillo E , Lanata L and Sarzi-Puttini P. Efficacy of ketoprofen vs ibuprofen and diclofenac for treating pain in patients with rheumatoid arthritis : A systematic review and meta-analysis. Arthritis and Rheumatology, 2014, 66, S1062
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf                                                                             31. Chen Y F , Jobanputra P , Barton P , Bryan S , Fry-Smith A , Harris G and Taylor R S. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam , celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis : a systematic review and economic evaluation (Structured abstract) . Centre for Reviews and Dissemination. Health Technology Assessment, 2008, 12(11), 1-178. Available from:   http://onlinelibrary.wiley.com/o/cochrane/cldare/articles/DARE-12008104813/frame.html
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
32. Shi W, Wang YM, Cheng NN, Chen BY, Li D.  Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritistreated with non-steroidal anti-inflammatory drugs. [Article in Chinese].   Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Nov;24(11):1044-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14687510
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
32. Shi W, Wang YM, Cheng NN, Chen BY, Li D.  Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritistreated with non-steroidal anti-inflammatory drugs. [Article in Chinese].   Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Nov;24(11):1044-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14687510
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
35. Alexandra N Colebatch , Jonathan L Marks and Christopher J Edwards. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis , ankylosing spondylitis, psoriatic arthritis , other spondyloarthritis). Cochrane Database of Systematic Reviews. Online Publication Date: November 2011. DOI: 10.1002/14651858.CD008872.pub2. Available from:   http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008872.pub2/full
 36. Jonathan L Marks , Alexandra N Colebatch , Rachelle Buchbinder and Christopher J Edwards. Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. Cochrane Database of Systematic Reviews. Online Publication Date: October 2011. DOI: 10.1002/14651858.CD008952.pub2 Available from:   http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008952.pub2/full
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
37. Martín-Mola E, Gijón-Baños J, Ansoleaga JJ.Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol Int. 1995;15(3):111-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8588120
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from: https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
31. Chen Y F , Jobanputra P , Barton P , Bryan S , Fry-Smith A , Harris G and Taylor R S. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam , celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis : a systematic review and economic evaluation (Structured abstract) . Centre for Reviews and Dissemination. Health Technology Assessment, 2008, 12(11), 1-178. Available from:   http://onlinelibrary.wiley.com/o/cochrane/cldare/articles/DARE-12008104813/frame.html
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full       38. Navarro-Millán I, Singh JA, Curtis JR.  Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor. Clin Ther. 2012 Apr;34(4):788-802.e3. doi: 10.1016/j.clinthera.2012.02.014. Epub 2012 Mar 22. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805022/
39. Jasvinder A Singh , Saba Beg and Maria Angeles Lopez-Olivo. Tocilizumab for rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: July 2010. DOI: 10.1002/14651858.CD008331.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008331.pub2/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full       40. Maria Angeles Lopez-Olivo , Matxalen Amezaga Urruela , Lynda McGahan , Eduardo N Pollono and Maria E Suarez-Almazor. Rituximab for rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: January 2015. DOI: 10.1002/14651858.CD007356.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007356.pub2/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full        41. Barbara BTB Blumenauer , Maria Judd , George A Wells   et al. Infliximab for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: July 2002. DOI: 10.1002/14651858.CD003785. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003785/full
42. Jasvinder A Singh , Robin Christensen , George A Wells et al. Biologics for rheumatoid arthritis : an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. Online Publication Date: October 2009. DOI: 10.1002/14651858.CD007848.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007848.pub2/full
69. Yoo DH , Racewicz A , Brzezicki J , Yatsyshyn R , Arteaga ET , Baranauskaite A , Abud-Mendoza C , Navarra S , Kadinov V , Sariego IG , Hong SS , Lee SY and Park W.
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis : 54-week results from the PLANETRA study. Arthritis research & therapy, 2016, 18(1):82-94 . Available from:   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818886/pdf/13075_2016_Article_981.pdf .
70.Takeuchi T , Yamanaka H , Tanaka Y , Sakurai T , Saito K , Ohtsubo H , Lee SJ and Nambu Y. Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis . Modern Rheumatology, 2015, 25(6 // *AstraZeneca*), 817. Available from:   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732515/

17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full       43. Anne Lethaby , Maria Angeles Lopez-Olivo , Lara J Maxwell , Amanda Burls , Peter Tugwell and George A Wells. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: May 2013. DOI: 10.1002/14651858.CD004525.pub2.  Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004525.pub2/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full       44. Federico Navarro-Sarabia , Rafael Ariza-Ariza , Blanca Hernandez-Cruz and Isidro Villanueva. Adalimumab for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: July 2005. DOI: 10.1002/14651858.CD005113.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005113.pub2/full
17. Singh J.A. et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research;  DOI 10.1002/acr.22783 VC 2015, American College of Rheumatology. Available from: http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf
20. Josef S. Smolen et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204573. Available from:  http://ard.bmj.com/content/early/2013/10/23/annrheumdis-2013-204573.full       5. Jasvinder A Singh , Shahrzad Noorbaloochi and Gurkirpal Singh. Golimumab  for rheumatoid  arthritis. Cochrane Database of Systematic Reviews. Online Online Publication Date: January 2010. DOI: 10.1002/14651858.CD008341. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008341/full
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from:
 https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
19. Management of early rheumatoid arthritis. (SIGN Guideline No 123). Available from:  http://www.sign.ac.uk/pdf/sign123.pdf
46. Jonathan L Marks , Alexandra N Colebatch , Rachelle Buchbinder and Christopher J Edwards. Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. Cochrane Database of Systematic Reviews. Online Publication Date: October 2011 DOI: 10.1002/14651858.CD008952.pub2.
Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008952.pub2/full
47. Samuel L Whittle , Bethan L Richards , Elaine Husni and Rachelle Buchbinder. Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database of Systematic Reviews. Online Publication Date: November 2011. DOI: 10.1002/14651858.CD003113.pub3
Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003113.pub3/full
48. Bekiarova P , Gerginova V and Sheitanov I. Clinical evaluation of the drug Mydocalm («gedeon richter») in patients with ankylosing spondylitis and spondyloarthrosis. [Bulgarian]
Revmatologiia (Moscow, Russia), 2000, 8(4), 41
53. Gaffney A, Gaffney P. Rheumatoid arthritis and heparin. Br J Rheumatol. 1996 Aug;35(8):808-9. Available from: http://rheumatology.oxfordjournals.org/content/35/8/808.long
54. H A E M van Heereveld, R Laan, F H J van den Hoogen, M Malefijt, I Novakova, and L B A van de Putte. Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement. Ann Rheum Dis. 2001 Oct; 60(10): 974–976. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1753387/
54. H A E M van Heereveld, R Laan, F H J van den Hoogen, M Malefijt, I Novakova, and L B A van de Putte. Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement. Ann Rheum Dis. 2001 Oct; 60(10): 974–976. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1753387/
49. Forrest CM, Stoy N, Stone TW, Harman G, Mackay GM, Oxford L, Darlington LG. Adenosine  and  cytokine levels following treatment of rheumatoid arthritis with dipyridamole. Rheumatol Int. 2006 Nov;27(1):11-7. Epub 2006 Sep 20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17021714
50. Usha PR , Naidu MUR and Datla R.  Clinical efficacy and tolerability evaluation of pentoxifylline in  rheumatoid arthritis : A double-blind, randomised, placebo-controlled study. Clinical drug investigation, 2002, 22(5), 329. Available from: http://link.springer.com/article/10.2165/00044011-200222050-00007
18. Rheumatoid arthritis in adults: management NICE guidelines [CG-79] Published date: February 2009. Last updated: December 2015. Available from:
 https://www.nice.org.uk/guidance/cg79/resources/rheumatoid-arthritis-in-adults-management-975636823525
51. Chen Y F , Jobanputra P , Barton P , Bryan S , Fry-Smith A , Harris G and Taylor R S. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis : a systematic review and economic evaluation (Structured abstract).Centre for Reviews and Dissemination. Health Technology Assessment, 2008, 12(11), 1-178. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18405470
52. tenWolde S , Dijkmans BA , Janssen M , Hermans J and Lamers CB. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. Alimentary pharmacology & therapeutics, 1996, 10(3), 347.  Available from: http://www.ncbi.nlm.nih.gov/pubmed/8791962
57. Borrás-Blasco J, Nuñez-Cornejo C, Gracia-Perez A, Rosique-Robles JD, Casterá MD, Viosca E, Abad FJ. Parapharyngeal abscess in a patient receiving etanercept. Ann Pharmacother. 2007 Feb;41(2):341-4. Epub 2007 Jan 16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17227824
58. Corrao G, Zambon A, Bertù L, Mauri A, Paleari V, Rossi C, Venegoni M. Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study. Drug Saf. 2006;29(10):889-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16970512/
55. Caperton EM , Heim-Duthoy KL , Matzke GR , Peterson PK and Johnson RC. Ceftriaxone therapy of chronic inflammatory arthritis . A double-blind placebo controlled trial. Archives of internal medicine, 1990, 150(8), 1677.  Available from: http://www.ncbi.nlm.nih.gov/pubmed/2383162   
60. Marshall DA , Hunter JA and Capell HA. Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases, 1992, 51(6), 758. Available from:  http://www.ncbi.nlm.nih.gov/pubmed/1616359
59. Al-Kaissi E and Al-Muhtaseb N. The influence of adding antibiotic in treatment of rheumatoid arthritis patients on Streptococcus pyogenes carrier rate and on the lipids profile. International Journal of Pharmacy and Pharmaceutical Sciences, 2015, 7(2), 245. Available from: http://innovareacademics.in/journals/index.php/ijpps/article/view/3916
61. Mowla K , Rajai E , Ghorbani A , Dargahi-Malamir M , Bahadoram M and Mohammadi S. Effect of atorvastatin on the disease activity and severity of rheumatoid arthritis : Double-blind randomized controlled trial. Journal of Clinical and Diagnostic Research, 2016, 10(5), OC32. Available from:  http://www.ncbi.nlm.nih.gov/pubmed/27437268
62. McCarey DW , McInnes IB , Madhok R , Hampson R , Scherbakov O , Ford I , Capell HA and Sattar N. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet (London, England), 2004, 363(9426), 2015. Available from:  http://www.ncbi.nlm.nih.gov/pubmed/15207950
63. Mikhael EM , Gorial FI and Majeed IA. Effect of rosuvastatin as adjuvant therapy to methotrexate on hematological parameters in patients with moderately-highly active rheumatoid arthritis. Journal of Experimental and Integrative Medicine, 2013, 3(2), 127. Available from:  http://www.scopemed.org/?mno=32513
64. Kumar P , Kennedy G , Khan F , Pullar T and Belch JJF. Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study. Scottish Medical Journal, 2012, 57(2), 80. Available from:   http://www.ncbi.nlm.nih.gov/pubmed/22555227
65. Beverley Shea , Michael V Swinden , Elizabeth Tanjong Ghogomu , Zulma Ortiz , Wanruchada Katchamart, Tamara Rader , Claire Bombardier , George A Wells and Peter Tugwell.  Folic acid and folinic acid  for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews. Online Publication Date: May 2013. DOI: 10.1002/14651858.CD000951.pub2. Available from:   http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000951.pub2/full
66.Chiang EP , Selhub J , Bagley PJ , Dallal G and Roubenoff R. Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients withrheumatoid arthritis . Arthritis research & therapy, 2005, 7(6), R1404. Available from:   http://www.ncbi.nlm.nih.gov/pubmed/16277693
67.Hamilton SF , Campbell NR , Kara M , Watson J and Connors M. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis. The Journal of rheumatology, 2003, 30(9), 1948. Available from:   http://www.ncbi.nlm.nih.gov/pubmed/12966595
68. Sofia Ramiro , Helga Radner , Désirée van der Heijde , Astrid van Tubergen , Rachelle Buchbinder , Daniel Aletaha and Robert BM Landewé. Combination therapy for pain management in inflammatory  arthritis (rheumatoid arthritis , ankylosing spondylitis, psoriatic arthritis , other spondyloarthritis). Cochrane Database of Systematic Reviews. Online Publication Date: October 2011. Available from:   http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008886.pub2/full 



Источник: diseases.medelement.com


Добавить комментарий